Companies: 48,687 Total Market Cap: 126956050782004.97

Scinai Immunotherapeutics Ltd.

NASDAQ: SCNI
Healthcare Biotechnology
Rank #44632
Market Cap 2.60 M
Volume 8,048
Price 2.78
Change (%) 0.36%
Country or region United States United States

Scinai Immunotherapeutics Ltd.'s latest marketcap:

2.60 M

As of May 2, 2025, Scinai Immunotherapeutics Ltd.'s market capitalization has reached $2.60 M. According to our data, Scinai Immunotherapeutics Ltd. is the 44632th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 2.60 M
Revenue (ttm) 452,000
Net Income (ttm) 4.70 M
Shares Out 933,679
EPS (ttm) 8.20
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date May 14, 2025
Market Cap Chart
Data Updated: May 2, 2025

Scinai Immunotherapeutics Ltd.'s yearly market capitalization.

Scinai Immunotherapeutics Ltd. has seen its market value drop from $11.20 M to $1.70 M since 2015, representing a total decrease of 84.82% and an annual compound decline rate (CAGR) of 18.34%.
Date Market Cap Change (%)
April 21, 2025 $1.70 M -41.38%
December 31, 2024 $2.90 M 31.82%
December 29, 2023 $2.20 M -60%
December 30, 2022 $5.50 M -83.68%
December 31, 2021 $33.70 M 5.64%
December 31, 2020 $31.90 M -65.85%
December 31, 2019 $93.40 M 199.36%
December 31, 2018 $31.20 M 72.38%
December 29, 2017 $18.10 M 60.18%
December 30, 2016 $11.30 M 0.89%
December 31, 2015 $11.20 M

Company Profile

Scinai Immunotherapeutics Ltd. was founded in 2003 in United States. on the Nasdaq Stock Market. With 31 employees, it focuses on Healthcare and aims to drive innovation in Biotechnology.
Frequently Asked Questions

As of May 2, 2025, Scinai Immunotherapeutics Ltd. (including the parent company, if applicable) has an estimated market capitalization of $2.60 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Scinai Immunotherapeutics Ltd. global market capitalization ranking is approximately 44632 as of May 2, 2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region United States
Founded 2003
IPO Date n/a
Employees 31
CEO
Sector Healthcare
Industry Biotechnology
Address